Pdb5 Estimación Del Costo Asociado a La Pérdida De Productividad Por Mortalidad Atribuible a La Diabetes en Argentina

Elgart, Jorge Federico; Caporale, JE; Pfirter, G; Gonzalez, L; Siri, F; Gagliardino, J.J.

doi:10.1016/s1098-3015(10)75395-x

Cited by 1 publication

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Concerning DALYs, a preliminary analysis carried out by CENEXA using the methodology developed by Murray and Lopez [ 8 ] showed that in 2005, diabetes alone (without any chronic complication), together with events of acute myocardial infarction (AMI) and stroke attributable to diabetes, accounted for 1,328,802 DALYs lost in the adult population; 85% of this burden was ascribed to disabilities. These results are explained by the chronic and progressive course of the disease [ 9 , 10 ].…”

Section: Resultsmentioning

confidence: 99%

“…Most of this burden affects women (60%; 793,011 DALYs) and people over 50 years old (52%; 694,694 DALYs). A preliminary sensitivity analysis conducted over r and K indicated that different scenarios (r = 0%, K = 1; r = 3%, K = 0; and r = 3%, K = 1) accounted for 90%, 69% and 60% of the base case recently reported (r = 0%, K = 0), respectively [ 9 , 10 ].…”

Section: Resultsmentioning

confidence: 99%

“…The data recorded showed that 80% of the people with Type 2 Diabetes Mellitus (T2DM) are overweight/obese (BMI≥25) [ 10 - 13 ], only 45% of them have HbA1c levels ≤7%, and 24% have systolic blood pressure (SBP)/diastolic blood pressure (DBP) ≤130/80 mm Hg. Furthermore, only around 5% of people with T2DM attain these three therapeutic goals – normal weight (BMI 18.50-24.99), glycaemic and blood pressure control - simultaneously (IDMPS third wave in Argentina, unpublished data).…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy

2013

View full text Add to dashboard Cite

BackgroundDiabetes is an expensive disease in Argentina as well as worldwide, and its prevalence is continuously rising affecting the quality of life of people with the disease and their life expectancy. It also imposes a heavy burden to the national health care budget and on the economy in the form of productivity losses.AimsTo review and discuss a) the reported evidence on diabetes prevalence, the degree of control, the cost of care and outcomes, b) available strategies to decrease the health and economic disease burden, and c) how the disease fits in the Argentinian health care system and policy. Finally, to propose evidence-based policy options to reduce the burden of diabetes, both from an epidemiological as well as an economic perspective, on the Argentinian society. The evidence presented is expected to help the local authorities to develop and implement effective diabetes care programmes.MethodologyA comprehensive literature review was performed using databases such as MEDLINE, EMBASE and LILACS (Latin American and Caribbean Health Sciences). Literature published from 1980 to 2011 was included. This information was complemented with grey literature, including data from national and provincial official sources, personal communications and contacts with health authorities and diabetes experts in Argentina.ResultsOverall diabetes prevalence increased from 8.4% in 2005 to 9.6% 2009 at national level. In 2009, diabetes was the seventh leading cause of death with a mortality rate of 19.2 per 100,000 inhabitants, and it accounted for 1,328,802 DALYs lost in the adult population, mainly affecting women aged over fifty. The per capita hospitalisation cost for people with diabetes was significantly higher than for people without the disease, US$ 1,628 vs. US$ 833 in 2004. Evidence shows that implementation of combined educative interventions improved quality of care and outcomes, decreased treatment costs and optimised the use of economic resources.ConclusionsBased on the evidence reviewed, we believe that the implementation of structured health care programmes including diabetes education at every level, could improve quality of care as well as its clinical, metabolic and economic outcomes. If implemented across the country, these programmes could decrease the disease burden and optimise the use of human and economic resources.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation